Similar articles

• No association between the polymorphisms in matrix metalloproteinase-1 and matrix metalloproteinase-3 promoter regions and colorectal cancer in Chinese.

  Xu E, Lai M, Lŭ B, Xing X, Huang Q. Xu E, et al. Dis Colon Rectum. 2006 Sep;49(9):1439-44. doi: 10.1007/s10350-006-0652-9. Dis Colon Rectum. 2006. PMID: 16937230
• Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer.

  Zinzindohoué F, Lecomte T, Ferraz JM, Houllier AM, Cugnenc PH, Berger A, Blons H, Laurent-Puig P. Zinzindohoué F, et al. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):594-9. Clin Cancer Res. 2005. PMID: 15701845
• Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer.

  Woo M, Park K, Nam J, Kim JC. Woo M, et al. J Gastroenterol Hepatol. 2007 Jul;22(7):1064-70. doi: 10.1111/j.1440-1746.2006.04424.x. J Gastroenterol Hepatol. 2007. PMID: 17608852
• [Matrix metalloproteinases and colorectal cancer].

  Roeb E, Matern S. Roeb E, et al. Med Klin (Munich). 2003 Dec 15;98(12):763-70. doi: 10.1007/s00063-003-1322-5. Med Klin (Munich). 2003. PMID: 14685678 Review. German.
• [Polymorphism in colorectal cancer].

  Hazama S, Oka M, Hinoda Y. Hazama S, et al. Nihon Rinsho. 2003 Sep;61 Suppl 7:42-6. Nihon Rinsho. 2003. PMID: 14574853 Review. Japanese. No abstract available.